nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—DHCR7—Doxorubicin—muscle cancer	0.207	0.258	CbGbCtD
Tamoxifen—ABCB11—Vincristine—muscle cancer	0.0526	0.0655	CbGbCtD
Tamoxifen—CYP1A1—Dacarbazine—muscle cancer	0.0432	0.0539	CbGbCtD
Tamoxifen—ABCG2—Dactinomycin—muscle cancer	0.0406	0.0506	CbGbCtD
Tamoxifen—CYP2E1—Dacarbazine—muscle cancer	0.0334	0.0416	CbGbCtD
Tamoxifen—ABCB11—Doxorubicin—muscle cancer	0.0328	0.041	CbGbCtD
Tamoxifen—CYP1B1—Doxorubicin—muscle cancer	0.0328	0.041	CbGbCtD
Tamoxifen—ABCC2—Vincristine—muscle cancer	0.0276	0.0345	CbGbCtD
Tamoxifen—ABCC2—Etoposide—muscle cancer	0.0253	0.0316	CbGbCtD
Tamoxifen—ABCG2—Vincristine—muscle cancer	0.025	0.0312	CbGbCtD
Tamoxifen—ABCG2—Etoposide—muscle cancer	0.0229	0.0286	CbGbCtD
Tamoxifen—CYP1A2—Dacarbazine—muscle cancer	0.0193	0.0241	CbGbCtD
Tamoxifen—CYP3A7—Vincristine—muscle cancer	0.0185	0.023	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0185	0.023	CbGbCtD
Tamoxifen—ABCC2—Doxorubicin—muscle cancer	0.0173	0.0215	CbGbCtD
Tamoxifen—ABCC2—Methotrexate—muscle cancer	0.0167	0.0209	CbGbCtD
Tamoxifen—CYP2E1—Etoposide—muscle cancer	0.0163	0.0204	CbGbCtD
Tamoxifen—ABCG2—Doxorubicin—muscle cancer	0.0156	0.0195	CbGbCtD
Tamoxifen—ABCG2—Methotrexate—muscle cancer	0.0151	0.0189	CbGbCtD
Tamoxifen—ABCB1—Dactinomycin—muscle cancer	0.0146	0.0182	CbGbCtD
Tamoxifen—CYP3A5—Vincristine—muscle cancer	0.0138	0.0173	CbGbCtD
Tamoxifen—CYP3A5—Etoposide—muscle cancer	0.0127	0.0158	CbGbCtD
Tamoxifen—CYP2C8—Etoposide—muscle cancer	0.0122	0.0152	CbGbCtD
Tamoxifen—CYP2B6—Doxorubicin—muscle cancer	0.011	0.0137	CbGbCtD
Tamoxifen—CYP1A2—Etoposide—muscle cancer	0.00944	0.0118	CbGbCtD
Tamoxifen—ABCB1—Vincristine—muscle cancer	0.00901	0.0112	CbGbCtD
Tamoxifen—ABCB1—Etoposide—muscle cancer	0.00826	0.0103	CbGbCtD
Tamoxifen—ABCB1—Doxorubicin—muscle cancer	0.00563	0.00702	CbGbCtD
Tamoxifen—ABCB1—Methotrexate—muscle cancer	0.00545	0.0068	CbGbCtD
Tamoxifen—CES1—larynx—muscle cancer	0.00542	0.0884	CbGeAlD
Tamoxifen—CYP3A4—Vincristine—muscle cancer	0.0054	0.00673	CbGbCtD
Tamoxifen—CYP2D6—Doxorubicin—muscle cancer	0.00531	0.00662	CbGbCtD
Tamoxifen—CYP3A4—Etoposide—muscle cancer	0.00495	0.00617	CbGbCtD
Tamoxifen—CYP3A4—Doxorubicin—muscle cancer	0.00337	0.00421	CbGbCtD
Tamoxifen—SULT1A1—renal system—muscle cancer	0.00187	0.0305	CbGeAlD
Tamoxifen—UGT1A4—renal system—muscle cancer	0.00163	0.0266	CbGeAlD
Tamoxifen—EBPL—head—muscle cancer	0.00157	0.0257	CbGeAlD
Tamoxifen—EBPL—testis—muscle cancer	0.00152	0.0248	CbGeAlD
Tamoxifen—SULT1A1—tendon—muscle cancer	0.00146	0.0238	CbGeAlD
Tamoxifen—SULT1A1—vagina—muscle cancer	0.00135	0.0221	CbGeAlD
Tamoxifen—FMO1—renal system—muscle cancer	0.00133	0.0217	CbGeAlD
Tamoxifen—ESRRA—renal system—muscle cancer	0.00131	0.0213	CbGeAlD
Tamoxifen—SULT1A1—head—muscle cancer	0.00125	0.0204	CbGeAlD
Tamoxifen—SULT1A1—testis—muscle cancer	0.00121	0.0197	CbGeAlD
Tamoxifen—DHCR7—cardiac atrium—muscle cancer	0.00119	0.0194	CbGeAlD
Tamoxifen—ESRRA—cardiac atrium—muscle cancer	0.00117	0.0191	CbGeAlD
Tamoxifen—FMO1—tendon—muscle cancer	0.00104	0.0169	CbGeAlD
Tamoxifen—ESRRA—tendon—muscle cancer	0.00102	0.0166	CbGeAlD
Tamoxifen—DHCR7—bone marrow—muscle cancer	0.001	0.0164	CbGeAlD
Tamoxifen—ESRRA—bone marrow—muscle cancer	0.000989	0.0161	CbGeAlD
Tamoxifen—DHCR7—vagina—muscle cancer	0.000963	0.0157	CbGeAlD
Tamoxifen—FMO1—vagina—muscle cancer	0.000963	0.0157	CbGeAlD
Tamoxifen—ESRRA—vagina—muscle cancer	0.000948	0.0154	CbGeAlD
Tamoxifen—DHCR7—head—muscle cancer	0.000889	0.0145	CbGeAlD
Tamoxifen—FMO1—head—muscle cancer	0.000889	0.0145	CbGeAlD
Tamoxifen—ESRRA—head—muscle cancer	0.000875	0.0143	CbGeAlD
Tamoxifen—DHCR7—testis—muscle cancer	0.000859	0.014	CbGeAlD
Tamoxifen—ESRRA—testis—muscle cancer	0.000846	0.0138	CbGeAlD
Tamoxifen—FMO3—vagina—muscle cancer	0.000832	0.0136	CbGeAlD
Tamoxifen—ESR2—smooth muscle tissue—muscle cancer	0.000816	0.0133	CbGeAlD
Tamoxifen—ESR2—renal system—muscle cancer	0.000785	0.0128	CbGeAlD
Tamoxifen—FMO3—head—muscle cancer	0.000769	0.0125	CbGeAlD
Tamoxifen—ABCB11—testis—muscle cancer	0.000751	0.0122	CbGeAlD
Tamoxifen—FMO3—testis—muscle cancer	0.000743	0.0121	CbGeAlD
Tamoxifen—ESR1—embryo—muscle cancer	0.000711	0.0116	CbGeAlD
Tamoxifen—SIGMAR1—smooth muscle tissue—muscle cancer	0.000632	0.0103	CbGeAlD
Tamoxifen—CES1—head—muscle cancer	0.000607	0.00989	CbGeAlD
Tamoxifen—CYP1B1—smooth muscle tissue—muscle cancer	0.000601	0.0098	CbGeAlD
Tamoxifen—ABCC2—renal system—muscle cancer	0.000591	0.00963	CbGeAlD
Tamoxifen—CES1—testis—muscle cancer	0.000586	0.00956	CbGeAlD
Tamoxifen—CYP1B1—renal system—muscle cancer	0.000579	0.00943	CbGeAlD
Tamoxifen—CYP2A6—vagina—muscle cancer	0.000572	0.00932	CbGeAlD
Tamoxifen—ESR2—vagina—muscle cancer	0.000569	0.00927	CbGeAlD
Tamoxifen—ESR1—smooth muscle tissue—muscle cancer	0.000559	0.00911	CbGeAlD
Tamoxifen—SIGMAR1—cardiac atrium—muscle cancer	0.000545	0.00888	CbGeAlD
Tamoxifen—ESR1—renal system—muscle cancer	0.000538	0.00877	CbGeAlD
Tamoxifen—ESR2—head—muscle cancer	0.000525	0.00857	CbGeAlD
Tamoxifen—ESR2—testis—muscle cancer	0.000508	0.00827	CbGeAlD
Tamoxifen—SIGMAR1—tendon—muscle cancer	0.000475	0.00774	CbGeAlD
Tamoxifen—ABCC2—tendon—muscle cancer	0.000461	0.00752	CbGeAlD
Tamoxifen—SIGMAR1—bone marrow—muscle cancer	0.00046	0.0075	CbGeAlD
Tamoxifen—CYP1B1—tendon—muscle cancer	0.000452	0.00736	CbGeAlD
Tamoxifen—CYP2C8—renal system—muscle cancer	0.000443	0.00722	CbGeAlD
Tamoxifen—SIGMAR1—vagina—muscle cancer	0.000441	0.00718	CbGeAlD
Tamoxifen—CYP1A2—renal system—muscle cancer	0.000415	0.00676	CbGeAlD
Tamoxifen—CYP19A1—head—muscle cancer	0.000414	0.00675	CbGeAlD
Tamoxifen—CYP1A1—renal system—muscle cancer	0.000409	0.00667	CbGeAlD
Tamoxifen—CYP19A1—testis—muscle cancer	0.0004	0.00652	CbGeAlD
Tamoxifen—CYP3A5—renal system—muscle cancer	0.0004	0.00652	CbGeAlD
Tamoxifen—CYP2B6—renal system—muscle cancer	0.000397	0.00648	CbGeAlD
Tamoxifen—SIGMAR1—testis—muscle cancer	0.000393	0.00641	CbGeAlD
Tamoxifen—ESR1—vagina—muscle cancer	0.00039	0.00635	CbGeAlD
Tamoxifen—CYP1B1—head—muscle cancer	0.000387	0.00631	CbGeAlD
Tamoxifen—ABCC2—testis—muscle cancer	0.000382	0.00622	CbGeAlD
Tamoxifen—CYP1B1—testis—muscle cancer	0.000374	0.0061	CbGeAlD
Tamoxifen—CYP2E1—renal system—muscle cancer	0.000373	0.00608	CbGeAlD
Tamoxifen—CYP2C19—vagina—muscle cancer	0.000368	0.00599	CbGeAlD
Tamoxifen—CYP1A1—cardiac atrium—muscle cancer	0.000366	0.00597	CbGeAlD
Tamoxifen—ESR1—head—muscle cancer	0.00036	0.00587	CbGeAlD
Tamoxifen—ESR1—testis—muscle cancer	0.000348	0.00567	CbGeAlD
Tamoxifen—Amenorrhoea—Doxorubicin—muscle cancer	0.000347	0.00258	CcSEcCtD
Tamoxifen—Cardiovascular disorder—Doxorubicin—muscle cancer	0.000347	0.00258	CcSEcCtD
Tamoxifen—Neutropenia—Etoposide—muscle cancer	0.000345	0.00256	CcSEcCtD
Tamoxifen—Skin exfoliation—Methotrexate—muscle cancer	0.000336	0.0025	CcSEcCtD
Tamoxifen—Arthropathy—Doxorubicin—muscle cancer	0.000335	0.00249	CcSEcCtD
Tamoxifen—Cough increased—Doxorubicin—muscle cancer	0.000333	0.00247	CcSEcCtD
Tamoxifen—Vaginal infection—Methotrexate—muscle cancer	0.000332	0.00247	CcSEcCtD
Tamoxifen—Pneumonia—Etoposide—muscle cancer	0.000331	0.00245	CcSEcCtD
Tamoxifen—Anaemia—Dactinomycin—muscle cancer	0.000328	0.00244	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.000326	0.00242	CcSEcCtD
Tamoxifen—ABCG2—bone marrow—muscle cancer	0.000326	0.00531	CbGeAlD
Tamoxifen—Acute coronary syndrome—Etoposide—muscle cancer	0.000324	0.00241	CcSEcCtD
Tamoxifen—Blood bilirubin increased—Doxorubicin—muscle cancer	0.000322	0.00239	CcSEcCtD
Tamoxifen—Myocardial infarction—Etoposide—muscle cancer	0.000322	0.00239	CcSEcCtD
Tamoxifen—Alopecia—Vincristine—muscle cancer	0.000322	0.00239	CcSEcCtD
Tamoxifen—CYP2C8—vagina—muscle cancer	0.000321	0.00523	CbGeAlD
Tamoxifen—Creatinine increased—Doxorubicin—muscle cancer	0.00032	0.00238	CcSEcCtD
Tamoxifen—Neoplasm—Methotrexate—muscle cancer	0.000318	0.00236	CcSEcCtD
Tamoxifen—Bone pain—Doxorubicin—muscle cancer	0.000318	0.00236	CcSEcCtD
Tamoxifen—Leukopenia—Dactinomycin—muscle cancer	0.000318	0.00236	CcSEcCtD
Tamoxifen—Inflammation—Doxorubicin—muscle cancer	0.000314	0.00233	CcSEcCtD
Tamoxifen—Gait disturbance—Doxorubicin—muscle cancer	0.000312	0.00232	CcSEcCtD
Tamoxifen—ABCG2—vagina—muscle cancer	0.000312	0.00509	CbGeAlD
Tamoxifen—Musculoskeletal pain—Doxorubicin—muscle cancer	0.000308	0.00229	CcSEcCtD
Tamoxifen—Back pain—Vincristine—muscle cancer	0.000307	0.00228	CcSEcCtD
Tamoxifen—Sepsis—Methotrexate—muscle cancer	0.000305	0.00227	CcSEcCtD
Tamoxifen—Pulmonary embolism—Doxorubicin—muscle cancer	0.000305	0.00226	CcSEcCtD
Tamoxifen—Hepatocellular injury—Doxorubicin—muscle cancer	0.000305	0.00226	CcSEcCtD
Tamoxifen—Vaginal inflammation—Doxorubicin—muscle cancer	0.000305	0.00226	CcSEcCtD
Tamoxifen—Myalgia—Dactinomycin—muscle cancer	0.000302	0.00224	CcSEcCtD
Tamoxifen—CYP3A4—renal system—muscle cancer	0.0003	0.00489	CbGeAlD
Tamoxifen—Discomfort—Dactinomycin—muscle cancer	0.000298	0.00222	CcSEcCtD
Tamoxifen—CYP1A1—vagina—muscle cancer	0.000296	0.00483	CbGeAlD
Tamoxifen—CYP2D6—renal system—muscle cancer	0.000295	0.00481	CbGeAlD
Tamoxifen—Hypoaesthesia—Etoposide—muscle cancer	0.000293	0.00218	CcSEcCtD
Tamoxifen—Anaemia—Vincristine—muscle cancer	0.000293	0.00218	CcSEcCtD
Tamoxifen—CYP2E1—tendon—muscle cancer	0.000291	0.00475	CbGeAlD
Tamoxifen—Skin exfoliation—Doxorubicin—muscle cancer	0.000291	0.00216	CcSEcCtD
Tamoxifen—CYP3A5—vagina—muscle cancer	0.00029	0.00472	CbGeAlD
Tamoxifen—Oedema—Dactinomycin—muscle cancer	0.00029	0.00215	CcSEcCtD
Tamoxifen—Fluid retention—Doxorubicin—muscle cancer	0.000289	0.00215	CcSEcCtD
Tamoxifen—CYP2B6—vagina—muscle cancer	0.000288	0.00469	CbGeAlD
Tamoxifen—Infection—Dactinomycin—muscle cancer	0.000288	0.00214	CcSEcCtD
Tamoxifen—Vaginal infection—Doxorubicin—muscle cancer	0.000288	0.00214	CcSEcCtD
Tamoxifen—CYP2C8—testis—muscle cancer	0.000286	0.00467	CbGeAlD
Tamoxifen—Hepatic failure—Methotrexate—muscle cancer	0.000284	0.00211	CcSEcCtD
Tamoxifen—Leukopenia—Vincristine—muscle cancer	0.000284	0.00211	CcSEcCtD
Tamoxifen—Thrombocytopenia—Dactinomycin—muscle cancer	0.000284	0.00211	CcSEcCtD
Tamoxifen—ABCB1—embryo—muscle cancer	0.000281	0.00458	CbGeAlD
Tamoxifen—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00028	0.00208	CcSEcCtD
Tamoxifen—Erythema multiforme—Etoposide—muscle cancer	0.000279	0.00207	CcSEcCtD
Tamoxifen—ABCG2—testis—muscle cancer	0.000278	0.00454	CbGeAlD
Tamoxifen—Anorexia—Dactinomycin—muscle cancer	0.000276	0.00205	CcSEcCtD
Tamoxifen—Neoplasm—Doxorubicin—muscle cancer	0.000275	0.00205	CcSEcCtD
Tamoxifen—Flushing—Etoposide—muscle cancer	0.000274	0.00203	CcSEcCtD
Tamoxifen—Hypertension—Vincristine—muscle cancer	0.000274	0.00203	CcSEcCtD
Tamoxifen—CYP1A1—head—muscle cancer	0.000274	0.00446	CbGeAlD
Tamoxifen—Myalgia—Vincristine—muscle cancer	0.00027	0.002	CcSEcCtD
Tamoxifen—Visual disturbance—Methotrexate—muscle cancer	0.00027	0.002	CcSEcCtD
Tamoxifen—CYP2B6—head—muscle cancer	0.000266	0.00433	CbGeAlD
Tamoxifen—Sepsis—Doxorubicin—muscle cancer	0.000264	0.00196	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000264	0.00196	CcSEcCtD
Tamoxifen—Alopecia—Etoposide—muscle cancer	0.000261	0.00194	CcSEcCtD
Tamoxifen—Oedema—Vincristine—muscle cancer	0.000259	0.00192	CcSEcCtD
Tamoxifen—Infection—Vincristine—muscle cancer	0.000257	0.00191	CcSEcCtD
Tamoxifen—CYP2B6—testis—muscle cancer	0.000257	0.00419	CbGeAlD
Tamoxifen—Osteoarthritis—Methotrexate—muscle cancer	0.000255	0.0019	CcSEcCtD
Tamoxifen—Thrombocytopenia—Vincristine—muscle cancer	0.000253	0.00188	CcSEcCtD
Tamoxifen—Hepatic function abnormal—Doxorubicin—muscle cancer	0.000253	0.00188	CcSEcCtD
Tamoxifen—Decreased appetite—Dactinomycin—muscle cancer	0.000252	0.00187	CcSEcCtD
Tamoxifen—Dysgeusia—Etoposide—muscle cancer	0.000251	0.00187	CcSEcCtD
Tamoxifen—Hyperhidrosis—Vincristine—muscle cancer	0.00025	0.00186	CcSEcCtD
Tamoxifen—Fatigue—Dactinomycin—muscle cancer	0.00025	0.00185	CcSEcCtD
Tamoxifen—CYP2E1—head—muscle cancer	0.00025	0.00407	CbGeAlD
Tamoxifen—Back pain—Etoposide—muscle cancer	0.000248	0.00184	CcSEcCtD
Tamoxifen—Pain—Dactinomycin—muscle cancer	0.000248	0.00184	CcSEcCtD
Tamoxifen—Muscle spasms—Etoposide—muscle cancer	0.000247	0.00183	CcSEcCtD
Tamoxifen—Anorexia—Vincristine—muscle cancer	0.000247	0.00183	CcSEcCtD
Tamoxifen—Hepatic failure—Doxorubicin—muscle cancer	0.000246	0.00183	CcSEcCtD
Tamoxifen—Mood swings—Methotrexate—muscle cancer	0.000242	0.0018	CcSEcCtD
Tamoxifen—CYP2E1—testis—muscle cancer	0.000241	0.00393	CbGeAlD
Tamoxifen—Anaemia—Etoposide—muscle cancer	0.000237	0.00176	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000237	0.00176	CcSEcCtD
Tamoxifen—Hot flush—Doxorubicin—muscle cancer	0.000236	0.00176	CcSEcCtD
Tamoxifen—Liver function test abnormal—Methotrexate—muscle cancer	0.000236	0.00175	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000236	0.00175	CcSEcCtD
Tamoxifen—Menopausal symptoms—Doxorubicin—muscle cancer	0.000234	0.00174	CcSEcCtD
Tamoxifen—Insomnia—Vincristine—muscle cancer	0.000234	0.00174	CcSEcCtD
Tamoxifen—Paraesthesia—Vincristine—muscle cancer	0.000232	0.00173	CcSEcCtD
Tamoxifen—Dermatitis bullous—Doxorubicin—muscle cancer	0.000231	0.00172	CcSEcCtD
Tamoxifen—Leukopenia—Etoposide—muscle cancer	0.00023	0.00171	CcSEcCtD
Tamoxifen—Abdominal pain—Dactinomycin—muscle cancer	0.000229	0.0017	CcSEcCtD
Tamoxifen—Decreased appetite—Vincristine—muscle cancer	0.000225	0.00167	CcSEcCtD
Tamoxifen—Cough—Etoposide—muscle cancer	0.000224	0.00166	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Vincristine—muscle cancer	0.000223	0.00166	CcSEcCtD
Tamoxifen—Fatigue—Vincristine—muscle cancer	0.000223	0.00166	CcSEcCtD
Tamoxifen—Hypertension—Etoposide—muscle cancer	0.000222	0.00165	CcSEcCtD
Tamoxifen—Pain—Vincristine—muscle cancer	0.000221	0.00164	CcSEcCtD
Tamoxifen—Constipation—Vincristine—muscle cancer	0.000221	0.00164	CcSEcCtD
Tamoxifen—Osteoarthritis—Doxorubicin—muscle cancer	0.000221	0.00164	CcSEcCtD
Tamoxifen—Chest pain—Etoposide—muscle cancer	0.000219	0.00162	CcSEcCtD
Tamoxifen—Pancreatitis—Methotrexate—muscle cancer	0.000216	0.00161	CcSEcCtD
Tamoxifen—Discomfort—Etoposide—muscle cancer	0.000216	0.0016	CcSEcCtD
Tamoxifen—Hypersensitivity—Dactinomycin—muscle cancer	0.000213	0.00158	CcSEcCtD
Tamoxifen—ABCB1—renal system—muscle cancer	0.000212	0.00346	CbGeAlD
Tamoxifen—Abdominal discomfort—Methotrexate—muscle cancer	0.000212	0.00157	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Vincristine—muscle cancer	0.000212	0.00157	CcSEcCtD
Tamoxifen—Pancytopenia—Methotrexate—muscle cancer	0.00021	0.00156	CcSEcCtD
Tamoxifen—Mood swings—Doxorubicin—muscle cancer	0.00021	0.00156	CcSEcCtD
Tamoxifen—Infection—Etoposide—muscle cancer	0.000208	0.00155	CcSEcCtD
Tamoxifen—Asthenia—Dactinomycin—muscle cancer	0.000208	0.00154	CcSEcCtD
Tamoxifen—Blood creatinine increased—Doxorubicin—muscle cancer	0.000207	0.00154	CcSEcCtD
Tamoxifen—Neutropenia—Methotrexate—muscle cancer	0.000206	0.00153	CcSEcCtD
Tamoxifen—Thrombocytopenia—Etoposide—muscle cancer	0.000205	0.00152	CcSEcCtD
Tamoxifen—Abdominal pain—Vincristine—muscle cancer	0.000205	0.00152	CcSEcCtD
Tamoxifen—Liver function test abnormal—Doxorubicin—muscle cancer	0.000204	0.00152	CcSEcCtD
Tamoxifen—Erectile dysfunction—Methotrexate—muscle cancer	0.000203	0.00151	CcSEcCtD
Tamoxifen—Hyperhidrosis—Etoposide—muscle cancer	0.000203	0.0015	CcSEcCtD
Tamoxifen—Anorexia—Etoposide—muscle cancer	0.0002	0.00148	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000199	0.00148	CcSEcCtD
Tamoxifen—Diarrhoea—Dactinomycin—muscle cancer	0.000198	0.00147	CcSEcCtD
Tamoxifen—Pneumonia—Methotrexate—muscle cancer	0.000198	0.00147	CcSEcCtD
Tamoxifen—CYP2D6—head—muscle cancer	0.000198	0.00322	CbGeAlD
Tamoxifen—Depression—Methotrexate—muscle cancer	0.000196	0.00146	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000195	0.00145	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000195	0.00145	CcSEcCtD
Tamoxifen—Influenza—Doxorubicin—muscle cancer	0.000191	0.00142	CcSEcCtD
Tamoxifen—Dysphagia—Doxorubicin—muscle cancer	0.000191	0.00142	CcSEcCtD
Tamoxifen—CYP2D6—testis—muscle cancer	0.000191	0.00311	CbGeAlD
Tamoxifen—Hypersensitivity—Vincristine—muscle cancer	0.000191	0.00142	CcSEcCtD
Tamoxifen—Sweating—Methotrexate—muscle cancer	0.000189	0.0014	CcSEcCtD
Tamoxifen—Paraesthesia—Etoposide—muscle cancer	0.000188	0.0014	CcSEcCtD
Tamoxifen—Pancreatitis—Doxorubicin—muscle cancer	0.000187	0.00139	CcSEcCtD
Tamoxifen—Dyspnoea—Etoposide—muscle cancer	0.000187	0.00139	CcSEcCtD
Tamoxifen—Angina pectoris—Doxorubicin—muscle cancer	0.000186	0.00138	CcSEcCtD
Tamoxifen—Asthenia—Vincristine—muscle cancer	0.000186	0.00138	CcSEcCtD
Tamoxifen—Vomiting—Dactinomycin—muscle cancer	0.000184	0.00137	CcSEcCtD
Tamoxifen—Bronchitis—Doxorubicin—muscle cancer	0.000184	0.00137	CcSEcCtD
Tamoxifen—Rash—Dactinomycin—muscle cancer	0.000183	0.00136	CcSEcCtD
Tamoxifen—Decreased appetite—Etoposide—muscle cancer	0.000182	0.00135	CcSEcCtD
Tamoxifen—Pancytopenia—Doxorubicin—muscle cancer	0.000182	0.00135	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Etoposide—muscle cancer	0.000181	0.00134	CcSEcCtD
Tamoxifen—Fatigue—Etoposide—muscle cancer	0.000181	0.00134	CcSEcCtD
Tamoxifen—Constipation—Etoposide—muscle cancer	0.000179	0.00133	CcSEcCtD
Tamoxifen—Pain—Etoposide—muscle cancer	0.000179	0.00133	CcSEcCtD
Tamoxifen—Neutropenia—Doxorubicin—muscle cancer	0.000179	0.00133	CcSEcCtD
Tamoxifen—Haemoglobin—Methotrexate—muscle cancer	0.000178	0.00132	CcSEcCtD
Tamoxifen—Diarrhoea—Vincristine—muscle cancer	0.000177	0.00131	CcSEcCtD
Tamoxifen—Haemorrhage—Methotrexate—muscle cancer	0.000177	0.00131	CcSEcCtD
Tamoxifen—Hepatitis—Methotrexate—muscle cancer	0.000177	0.00131	CcSEcCtD
Tamoxifen—Pharyngitis—Methotrexate—muscle cancer	0.000175	0.0013	CcSEcCtD
Tamoxifen—Weight increased—Doxorubicin—muscle cancer	0.000174	0.00129	CcSEcCtD
Tamoxifen—Weight decreased—Doxorubicin—muscle cancer	0.000173	0.00128	CcSEcCtD
Tamoxifen—Nausea—Dactinomycin—muscle cancer	0.000172	0.00128	CcSEcCtD
Tamoxifen—Pneumonia—Doxorubicin—muscle cancer	0.000171	0.00127	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Etoposide—muscle cancer	0.000171	0.00127	CcSEcCtD
Tamoxifen—Dizziness—Vincristine—muscle cancer	0.000171	0.00127	CcSEcCtD
Tamoxifen—Visual impairment—Methotrexate—muscle cancer	0.00017	0.00126	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000169	0.00126	CcSEcCtD
Tamoxifen—Erythema multiforme—Methotrexate—muscle cancer	0.000167	0.00124	CcSEcCtD
Tamoxifen—Urticaria—Etoposide—muscle cancer	0.000166	0.00124	CcSEcCtD
Tamoxifen—Abdominal pain—Etoposide—muscle cancer	0.000166	0.00123	CcSEcCtD
Tamoxifen—Urinary tract infection—Doxorubicin—muscle cancer	0.000166	0.00123	CcSEcCtD
Tamoxifen—Vomiting—Vincristine—muscle cancer	0.000164	0.00122	CcSEcCtD
Tamoxifen—Sweating—Doxorubicin—muscle cancer	0.000163	0.00121	CcSEcCtD
Tamoxifen—Rash—Vincristine—muscle cancer	0.000163	0.00121	CcSEcCtD
Tamoxifen—Dermatitis—Vincristine—muscle cancer	0.000163	0.00121	CcSEcCtD
Tamoxifen—Headache—Vincristine—muscle cancer	0.000162	0.0012	CcSEcCtD
Tamoxifen—ABCB1—bone marrow—muscle cancer	0.000161	0.00262	CbGeAlD
Tamoxifen—Sinusitis—Doxorubicin—muscle cancer	0.00016	0.00119	CcSEcCtD
Tamoxifen—Alopecia—Methotrexate—muscle cancer	0.000156	0.00116	CcSEcCtD
Tamoxifen—Hypersensitivity—Etoposide—muscle cancer	0.000154	0.00115	CcSEcCtD
Tamoxifen—ABCB1—vagina—muscle cancer	0.000154	0.00251	CbGeAlD
Tamoxifen—Erythema—Methotrexate—muscle cancer	0.000154	0.00114	CcSEcCtD
Tamoxifen—Haemoglobin—Doxorubicin—muscle cancer	0.000154	0.00114	CcSEcCtD
Tamoxifen—Nausea—Vincristine—muscle cancer	0.000154	0.00114	CcSEcCtD
Tamoxifen—Haemorrhage—Doxorubicin—muscle cancer	0.000153	0.00114	CcSEcCtD
Tamoxifen—Hepatitis—Doxorubicin—muscle cancer	0.000153	0.00114	CcSEcCtD
Tamoxifen—Hypoaesthesia—Doxorubicin—muscle cancer	0.000152	0.00113	CcSEcCtD
Tamoxifen—Pharyngitis—Doxorubicin—muscle cancer	0.000152	0.00113	CcSEcCtD
Tamoxifen—Oedema peripheral—Doxorubicin—muscle cancer	0.000151	0.00112	CcSEcCtD
Tamoxifen—Dysgeusia—Methotrexate—muscle cancer	0.000151	0.00112	CcSEcCtD
Tamoxifen—Asthenia—Etoposide—muscle cancer	0.00015	0.00112	CcSEcCtD
Tamoxifen—Back pain—Methotrexate—muscle cancer	0.000149	0.00111	CcSEcCtD
Tamoxifen—Pruritus—Etoposide—muscle cancer	0.000148	0.0011	CcSEcCtD
Tamoxifen—Visual impairment—Doxorubicin—muscle cancer	0.000147	0.0011	CcSEcCtD
Tamoxifen—Erythema multiforme—Doxorubicin—muscle cancer	0.000145	0.00107	CcSEcCtD
Tamoxifen—Diarrhoea—Etoposide—muscle cancer	0.000143	0.00107	CcSEcCtD
Tamoxifen—Anaemia—Methotrexate—muscle cancer	0.000142	0.00106	CcSEcCtD
Tamoxifen—ABCB1—head—muscle cancer	0.000142	0.00232	CbGeAlD
Tamoxifen—Flushing—Doxorubicin—muscle cancer	0.000142	0.00105	CcSEcCtD
Tamoxifen—Dizziness—Etoposide—muscle cancer	0.000139	0.00103	CcSEcCtD
Tamoxifen—Leukopenia—Methotrexate—muscle cancer	0.000138	0.00102	CcSEcCtD
Tamoxifen—ABCB1—testis—muscle cancer	0.000137	0.00224	CbGeAlD
Tamoxifen—Arrhythmia—Doxorubicin—muscle cancer	0.000137	0.00102	CcSEcCtD
Tamoxifen—Alopecia—Doxorubicin—muscle cancer	0.000135	0.001	CcSEcCtD
Tamoxifen—Cough—Methotrexate—muscle cancer	0.000134	0.000997	CcSEcCtD
Tamoxifen—Vomiting—Etoposide—muscle cancer	0.000133	0.00099	CcSEcCtD
Tamoxifen—Erythema—Doxorubicin—muscle cancer	0.000133	0.000989	CcSEcCtD
Tamoxifen—Rash—Etoposide—muscle cancer	0.000132	0.000981	CcSEcCtD
Tamoxifen—Dermatitis—Etoposide—muscle cancer	0.000132	0.000981	CcSEcCtD
Tamoxifen—Headache—Etoposide—muscle cancer	0.000131	0.000975	CcSEcCtD
Tamoxifen—Arthralgia—Methotrexate—muscle cancer	0.000131	0.000973	CcSEcCtD
Tamoxifen—Chest pain—Methotrexate—muscle cancer	0.000131	0.000973	CcSEcCtD
Tamoxifen—Myalgia—Methotrexate—muscle cancer	0.000131	0.000973	CcSEcCtD
Tamoxifen—Dysgeusia—Doxorubicin—muscle cancer	0.00013	0.000969	CcSEcCtD
Tamoxifen—Discomfort—Methotrexate—muscle cancer	0.000129	0.000961	CcSEcCtD
Tamoxifen—Back pain—Doxorubicin—muscle cancer	0.000129	0.000957	CcSEcCtD
Tamoxifen—Muscle spasms—Doxorubicin—muscle cancer	0.000128	0.000951	CcSEcCtD
Tamoxifen—Infection—Methotrexate—muscle cancer	0.000125	0.000926	CcSEcCtD
Tamoxifen—Nausea—Etoposide—muscle cancer	0.000124	0.000925	CcSEcCtD
Tamoxifen—CES1—E2F transcription factor network—TFE3—muscle cancer	0.000123	0.0569	CbGpPWpGaD
Tamoxifen—Anaemia—Doxorubicin—muscle cancer	0.000123	0.000914	CcSEcCtD
Tamoxifen—Thrombocytopenia—Methotrexate—muscle cancer	0.000123	0.000913	CcSEcCtD
Tamoxifen—Hyperhidrosis—Methotrexate—muscle cancer	0.000121	0.000901	CcSEcCtD
Tamoxifen—Anorexia—Methotrexate—muscle cancer	0.00012	0.000889	CcSEcCtD
Tamoxifen—Leukopenia—Doxorubicin—muscle cancer	0.000119	0.000886	CcSEcCtD
Tamoxifen—Cough—Doxorubicin—muscle cancer	0.000116	0.000863	CcSEcCtD
Tamoxifen—Hypertension—Doxorubicin—muscle cancer	0.000115	0.000854	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000114	0.000849	CcSEcCtD
Tamoxifen—Insomnia—Methotrexate—muscle cancer	0.000114	0.000843	CcSEcCtD
Tamoxifen—Myalgia—Doxorubicin—muscle cancer	0.000113	0.000842	CcSEcCtD
Tamoxifen—Chest pain—Doxorubicin—muscle cancer	0.000113	0.000842	CcSEcCtD
Tamoxifen—Arthralgia—Doxorubicin—muscle cancer	0.000113	0.000842	CcSEcCtD
Tamoxifen—Anxiety—Doxorubicin—muscle cancer	0.000113	0.000839	CcSEcCtD
Tamoxifen—Paraesthesia—Methotrexate—muscle cancer	0.000113	0.000837	CcSEcCtD
Tamoxifen—Discomfort—Doxorubicin—muscle cancer	0.000112	0.000832	CcSEcCtD
Tamoxifen—Dyspnoea—Methotrexate—muscle cancer	0.000112	0.000831	CcSEcCtD
Tamoxifen—Dry mouth—Doxorubicin—muscle cancer	0.000111	0.000824	CcSEcCtD
Tamoxifen—Dyspepsia—Methotrexate—muscle cancer	0.00011	0.000821	CcSEcCtD
Tamoxifen—Decreased appetite—Methotrexate—muscle cancer	0.000109	0.000811	CcSEcCtD
Tamoxifen—Oedema—Doxorubicin—muscle cancer	0.000109	0.000807	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000108	0.000805	CcSEcCtD
Tamoxifen—Fatigue—Methotrexate—muscle cancer	0.000108	0.000804	CcSEcCtD
Tamoxifen—Infection—Doxorubicin—muscle cancer	0.000108	0.000802	CcSEcCtD
Tamoxifen—SULT1A1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000108	0.0497	CbGpPWpGaD
Tamoxifen—Pain—Methotrexate—muscle cancer	0.000107	0.000797	CcSEcCtD
Tamoxifen—Thrombocytopenia—Doxorubicin—muscle cancer	0.000106	0.000791	CcSEcCtD
Tamoxifen—Hyperhidrosis—Doxorubicin—muscle cancer	0.000105	0.000781	CcSEcCtD
Tamoxifen—Anorexia—Doxorubicin—muscle cancer	0.000104	0.00077	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Methotrexate—muscle cancer	0.000103	0.000762	CcSEcCtD
Tamoxifen—Urticaria—Methotrexate—muscle cancer	9.97e-05	0.000741	CcSEcCtD
Tamoxifen—Abdominal pain—Methotrexate—muscle cancer	9.92e-05	0.000737	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Doxorubicin—muscle cancer	9.9e-05	0.000736	CcSEcCtD
Tamoxifen—Insomnia—Doxorubicin—muscle cancer	9.83e-05	0.00073	CcSEcCtD
Tamoxifen—Paraesthesia—Doxorubicin—muscle cancer	9.76e-05	0.000725	CcSEcCtD
Tamoxifen—Dyspnoea—Doxorubicin—muscle cancer	9.69e-05	0.00072	CcSEcCtD
Tamoxifen—Dyspepsia—Doxorubicin—muscle cancer	9.57e-05	0.000711	CcSEcCtD
Tamoxifen—Decreased appetite—Doxorubicin—muscle cancer	9.45e-05	0.000702	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Doxorubicin—muscle cancer	9.38e-05	0.000697	CcSEcCtD
Tamoxifen—Fatigue—Doxorubicin—muscle cancer	9.37e-05	0.000696	CcSEcCtD
Tamoxifen—Constipation—Doxorubicin—muscle cancer	9.3e-05	0.00069	CcSEcCtD
Tamoxifen—Pain—Doxorubicin—muscle cancer	9.3e-05	0.00069	CcSEcCtD
Tamoxifen—Hypersensitivity—Methotrexate—muscle cancer	9.25e-05	0.000687	CcSEcCtD
Tamoxifen—Asthenia—Methotrexate—muscle cancer	9.01e-05	0.000669	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Doxorubicin—muscle cancer	8.89e-05	0.00066	CcSEcCtD
Tamoxifen—Pruritus—Methotrexate—muscle cancer	8.88e-05	0.00066	CcSEcCtD
Tamoxifen—Urticaria—Doxorubicin—muscle cancer	8.64e-05	0.000641	CcSEcCtD
Tamoxifen—Abdominal pain—Doxorubicin—muscle cancer	8.59e-05	0.000638	CcSEcCtD
Tamoxifen—Diarrhoea—Methotrexate—muscle cancer	8.59e-05	0.000638	CcSEcCtD
Tamoxifen—CES1—E2F transcription factor network—TP73—muscle cancer	8.34e-05	0.0384	CbGpPWpGaD
Tamoxifen—Dizziness—Methotrexate—muscle cancer	8.3e-05	0.000617	CcSEcCtD
Tamoxifen—Hypersensitivity—Doxorubicin—muscle cancer	8.01e-05	0.000595	CcSEcCtD
Tamoxifen—Vomiting—Methotrexate—muscle cancer	7.98e-05	0.000593	CcSEcCtD
Tamoxifen—Rash—Methotrexate—muscle cancer	7.91e-05	0.000588	CcSEcCtD
Tamoxifen—Dermatitis—Methotrexate—muscle cancer	7.91e-05	0.000587	CcSEcCtD
Tamoxifen—Headache—Methotrexate—muscle cancer	7.86e-05	0.000584	CcSEcCtD
Tamoxifen—ESRRA—Preimplantation Embryo—HMGA1—muscle cancer	7.81e-05	0.036	CbGpPWpGaD
Tamoxifen—Asthenia—Doxorubicin—muscle cancer	7.8e-05	0.000579	CcSEcCtD
Tamoxifen—Pruritus—Doxorubicin—muscle cancer	7.69e-05	0.000571	CcSEcCtD
Tamoxifen—Nausea—Methotrexate—muscle cancer	7.46e-05	0.000554	CcSEcCtD
Tamoxifen—Diarrhoea—Doxorubicin—muscle cancer	7.44e-05	0.000552	CcSEcCtD
Tamoxifen—Dizziness—Doxorubicin—muscle cancer	7.19e-05	0.000534	CcSEcCtD
Tamoxifen—Vomiting—Doxorubicin—muscle cancer	6.91e-05	0.000513	CcSEcCtD
Tamoxifen—Rash—Doxorubicin—muscle cancer	6.85e-05	0.000509	CcSEcCtD
Tamoxifen—Dermatitis—Doxorubicin—muscle cancer	6.85e-05	0.000509	CcSEcCtD
Tamoxifen—Headache—Doxorubicin—muscle cancer	6.81e-05	0.000506	CcSEcCtD
Tamoxifen—Nausea—Doxorubicin—muscle cancer	6.46e-05	0.00048	CcSEcCtD
Tamoxifen—ESRRA—PPARA activates gene expression—MED12—muscle cancer	5.65e-05	0.026	CbGpPWpGaD
Tamoxifen—ESRRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	5.53e-05	0.0255	CbGpPWpGaD
Tamoxifen—UGT1A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	5.36e-05	0.0247	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of nuclear SMAD2/3 signaling—TFE3—muscle cancer	4.6e-05	0.0212	CbGpPWpGaD
Tamoxifen—FMO3—SIDS Susceptibility Pathways—TP73—muscle cancer	4.4e-05	0.0203	CbGpPWpGaD
Tamoxifen—ESRRA—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	3.81e-05	0.0176	CbGpPWpGaD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—TP73—muscle cancer	3.64e-05	0.0168	CbGpPWpGaD
Tamoxifen—CYP19A1—FSH signaling pathway—FOXO1—muscle cancer	3.42e-05	0.0158	CbGpPWpGaD
Tamoxifen—CYP1B1—Melatonin metabolism and effects—FOXO1—muscle cancer	3.11e-05	0.0143	CbGpPWpGaD
Tamoxifen—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	3.01e-05	0.0139	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of Telomerase—WT1—muscle cancer	2.71e-05	0.0125	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of nuclear SMAD2/3 signaling—MYOD1—muscle cancer	2.53e-05	0.0117	CbGpPWpGaD
Tamoxifen—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—muscle cancer	2.39e-05	0.011	CbGpPWpGaD
Tamoxifen—CYP2A6—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	2.37e-05	0.0109	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	2.35e-05	0.0108	CbGpPWpGaD
Tamoxifen—CES1—Fluoropyrimidine Activity—TP53—muscle cancer	2.22e-05	0.0102	CbGpPWpGaD
Tamoxifen—CES1—E2F transcription factor network—CDKN2A—muscle cancer	2.11e-05	0.00973	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2e-05	0.00923	CbGpPWpGaD
Tamoxifen—CYP2B6—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	1.92e-05	0.00883	CbGpPWpGaD
Tamoxifen—CYP1A1—Melatonin metabolism and effects—FOXO1—muscle cancer	1.91e-05	0.00883	CbGpPWpGaD
Tamoxifen—EBP—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.9e-05	0.00875	CbGpPWpGaD
Tamoxifen—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—muscle cancer	1.88e-05	0.00869	CbGpPWpGaD
Tamoxifen—CYP3A5—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	1.87e-05	0.00863	CbGpPWpGaD
Tamoxifen—ESRRA—Generic Transcription Pathway—MED12—muscle cancer	1.8e-05	0.00832	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO4—muscle cancer	1.72e-05	0.00793	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	1.72e-05	0.00792	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—FH—muscle cancer	1.58e-05	0.00727	CbGpPWpGaD
Tamoxifen—CYP2C19—Melatonin metabolism and effects—FOXO1—muscle cancer	1.57e-05	0.00722	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—FH—muscle cancer	1.55e-05	0.00714	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.52e-05	0.00699	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—FH—muscle cancer	1.5e-05	0.00689	CbGpPWpGaD
Tamoxifen—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	1.45e-05	0.00668	CbGpPWpGaD
Tamoxifen—CYP2D6—Melatonin metabolism and effects—FOXO1—muscle cancer	1.44e-05	0.00664	CbGpPWpGaD
Tamoxifen—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—muscle cancer	1.44e-05	0.00663	CbGpPWpGaD
Tamoxifen—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	1.42e-05	0.00653	CbGpPWpGaD
Tamoxifen—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	1.41e-05	0.00652	CbGpPWpGaD
Tamoxifen—ESR1—Leptin signaling pathway—FOXO1—muscle cancer	1.35e-05	0.00623	CbGpPWpGaD
Tamoxifen—CYP19A1—Tryptophan metabolism—MDM2—muscle cancer	1.34e-05	0.00617	CbGpPWpGaD
Tamoxifen—ESR1—FOXM1 transcription factor network—CDKN2A—muscle cancer	1.33e-05	0.00613	CbGpPWpGaD
Tamoxifen—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	1.32e-05	0.00609	CbGpPWpGaD
Tamoxifen—CYP1B1—Tryptophan metabolism—MDM2—muscle cancer	1.29e-05	0.00595	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—FH—muscle cancer	1.29e-05	0.00593	CbGpPWpGaD
Tamoxifen—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO1—muscle cancer	1.27e-05	0.00586	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	1.24e-05	0.00573	CbGpPWpGaD
Tamoxifen—CYP1A2—Melatonin metabolism and effects—FOXO1—muscle cancer	1.22e-05	0.00563	CbGpPWpGaD
Tamoxifen—CYP1A1—PPARA activates gene expression—MED12—muscle cancer	1.2e-05	0.00553	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—FH—muscle cancer	1.2e-05	0.00551	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	1.18e-05	0.00546	CbGpPWpGaD
Tamoxifen—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	1.17e-05	0.00542	CbGpPWpGaD
Tamoxifen—CYP1B1—Arachidonic acid metabolism—PTGS2—muscle cancer	1.16e-05	0.00536	CbGpPWpGaD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	1.16e-05	0.00533	CbGpPWpGaD
Tamoxifen—ESR2—Generic Transcription Pathway—MED12—muscle cancer	1.15e-05	0.00529	CbGpPWpGaD
Tamoxifen—ABCG2—HIF-2-alpha transcription factor network—VEGFA—muscle cancer	1.13e-05	0.00523	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—FOXO4—muscle cancer	1.04e-05	0.00479	CbGpPWpGaD
Tamoxifen—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	9.79e-06	0.00452	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—FH—muscle cancer	9.19e-06	0.00424	CbGpPWpGaD
Tamoxifen—ESR1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	9.1e-06	0.0042	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—MED12—muscle cancer	8.91e-06	0.00411	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—CDKN2A—muscle cancer	8.83e-06	0.00407	CbGpPWpGaD
Tamoxifen—ABCG2—Fluoropyrimidine Activity—TP53—muscle cancer	8.78e-06	0.00405	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—MED12—muscle cancer	8.75e-06	0.00403	CbGpPWpGaD
Tamoxifen—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	8.71e-06	0.00401	CbGpPWpGaD
Tamoxifen—ESRRA—Gene Expression—MED12—muscle cancer	8.69e-06	0.004	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	8.66e-06	0.00399	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	8.62e-06	0.00398	CbGpPWpGaD
Tamoxifen—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—muscle cancer	8.56e-06	0.00395	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—MED12—muscle cancer	8.45e-06	0.0039	CbGpPWpGaD
Tamoxifen—CYP2E1—Tryptophan metabolism—MDM2—muscle cancer	8.42e-06	0.00388	CbGpPWpGaD
Tamoxifen—FMO3—SIDS Susceptibility Pathways—VEGFA—muscle cancer	8.21e-06	0.00379	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—ENO2—muscle cancer	8.12e-06	0.00375	CbGpPWpGaD
Tamoxifen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	8.09e-06	0.00373	CbGpPWpGaD
Tamoxifen—CYP2A6—Fluoropyrimidine Activity—TP53—muscle cancer	7.98e-06	0.00368	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—ENO2—muscle cancer	7.97e-06	0.00368	CbGpPWpGaD
Tamoxifen—CYP1A1—Tryptophan metabolism—MDM2—muscle cancer	7.94e-06	0.00366	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	7.72e-06	0.00356	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—ENO2—muscle cancer	7.7e-06	0.00355	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—FH—muscle cancer	7.7e-06	0.00355	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—FOXO1—muscle cancer	7.68e-06	0.00354	CbGpPWpGaD
Tamoxifen—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	7.66e-06	0.00353	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	7.66e-06	0.00353	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	7.61e-06	0.00351	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	7.34e-06	0.00338	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—MED12—muscle cancer	7.26e-06	0.00335	CbGpPWpGaD
Tamoxifen—ESR1—LKB1 signaling events—TP53—muscle cancer	7.26e-06	0.00335	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—MED12—muscle cancer	7.2e-06	0.00332	CbGpPWpGaD
Tamoxifen—CYP1A1—Arachidonic acid metabolism—PTGS2—muscle cancer	7.16e-06	0.0033	CbGpPWpGaD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—VEGFA—muscle cancer	6.8e-06	0.00313	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—MED12—muscle cancer	6.75e-06	0.00311	CbGpPWpGaD
Tamoxifen—ABCG2—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	6.67e-06	0.00308	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—ENO2—muscle cancer	6.62e-06	0.00305	CbGpPWpGaD
Tamoxifen—CYP2C8—Arachidonic acid metabolism—PTGS2—muscle cancer	6.57e-06	0.00303	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	6.35e-06	0.00293	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	6.27e-06	0.00289	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—ENO2—muscle cancer	6.16e-06	0.00284	CbGpPWpGaD
Tamoxifen—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	6.03e-06	0.00278	CbGpPWpGaD
Tamoxifen—EBP—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	6.02e-06	0.00278	CbGpPWpGaD
Tamoxifen—CYP2C19—Arachidonic acid metabolism—PTGS2—muscle cancer	5.86e-06	0.0027	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—KIT—muscle cancer	5.85e-06	0.0027	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—MED12—muscle cancer	5.79e-06	0.00267	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	5.78e-06	0.00267	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—FH—muscle cancer	5.68e-06	0.00262	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—MED12—muscle cancer	5.53e-06	0.00255	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.44e-06	0.00251	CbGpPWpGaD
Tamoxifen—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	5.34e-06	0.00246	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.23e-06	0.00241	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—MED12—muscle cancer	5.19e-06	0.00239	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—MDM2—muscle cancer	5.17e-06	0.00239	CbGpPWpGaD
Tamoxifen—CYP1A2—Tryptophan metabolism—MDM2—muscle cancer	5.06e-06	0.00233	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—TP53—muscle cancer	4.92e-06	0.00227	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	4.88e-06	0.00225	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.82e-06	0.00222	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—ENO2—muscle cancer	4.73e-06	0.00218	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—MDM2—muscle cancer	4.63e-06	0.00214	CbGpPWpGaD
Tamoxifen—ESR1—Signaling by ERBB4—MDM2—muscle cancer	4.61e-06	0.00212	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	4.58e-06	0.00211	CbGpPWpGaD
Tamoxifen—CYP1A2—Arachidonic acid metabolism—PTGS2—muscle cancer	4.57e-06	0.00211	CbGpPWpGaD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	4.37e-06	0.00201	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—MED12—muscle cancer	4.35e-06	0.00201	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—FH—muscle cancer	4.28e-06	0.00198	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—FH—muscle cancer	4.13e-06	0.0019	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KIDINS220—muscle cancer	3.98e-06	0.00183	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—ENO2—muscle cancer	3.97e-06	0.00183	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	3.93e-06	0.00181	CbGpPWpGaD
Tamoxifen—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	3.91e-06	0.0018	CbGpPWpGaD
Tamoxifen—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	3.85e-06	0.00177	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	3.84e-06	0.00177	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—FH—muscle cancer	3.75e-06	0.00173	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—FH—muscle cancer	3.72e-06	0.00172	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	3.7e-06	0.00171	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	3.61e-06	0.00166	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	3.52e-06	0.00162	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—FH—muscle cancer	3.41e-06	0.00157	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.22e-06	0.00149	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—MED12—muscle cancer	3.21e-06	0.00148	CbGpPWpGaD
Tamoxifen—ABCB1—Allograft Rejection—VEGFA—muscle cancer	3.13e-06	0.00144	CbGpPWpGaD
Tamoxifen—CYP19A1—Integrated Breast Cancer Pathway—TP53—muscle cancer	2.97e-06	0.00137	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.96e-06	0.00136	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ENO2—muscle cancer	2.93e-06	0.00135	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	2.91e-06	0.00134	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—PTGS2—muscle cancer	2.83e-06	0.0013	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MED12—muscle cancer	2.79e-06	0.00129	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—PTGS2—muscle cancer	2.78e-06	0.00128	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—FH—muscle cancer	2.75e-06	0.00127	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—FH—muscle cancer	2.69e-06	0.00124	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—FH—muscle cancer	2.69e-06	0.00124	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—PTGS2—muscle cancer	2.68e-06	0.00124	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Breast Cancer Pathway—TP53—muscle cancer	2.66e-06	0.00123	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.64e-06	0.00122	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—FH—muscle cancer	2.54e-06	0.00117	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—MED12—muscle cancer	2.42e-06	0.00112	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.41e-06	0.00111	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—MED12—muscle cancer	2.33e-06	0.00107	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—FH—muscle cancer	2.33e-06	0.00107	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—PTGS2—muscle cancer	2.31e-06	0.00106	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.29e-06	0.00105	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ENO2—muscle cancer	2.21e-06	0.00102	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	2.2e-06	0.00102	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—PTGS2—muscle cancer	2.14e-06	0.000989	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ENO2—muscle cancer	2.13e-06	0.00098	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—MED12—muscle cancer	2.12e-06	0.000978	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—MED12—muscle cancer	2.1e-06	0.000969	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—FH—muscle cancer	2.08e-06	0.000959	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.06e-06	0.000948	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	2.03e-06	0.000936	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—FH—muscle cancer	2.03e-06	0.000936	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	1.96e-06	0.000903	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ENO2—muscle cancer	1.93e-06	0.000892	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—MED12—muscle cancer	1.93e-06	0.000888	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ENO2—muscle cancer	1.92e-06	0.000884	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—FH—muscle cancer	1.91e-06	0.000882	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—FH—muscle cancer	1.9e-06	0.000874	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ENO2—muscle cancer	1.76e-06	0.00081	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.73e-06	0.000796	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.66e-06	0.000766	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—PTGS2—muscle cancer	1.65e-06	0.00076	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—FH—muscle cancer	1.62e-06	0.000747	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTCH1—muscle cancer	1.57e-06	0.000722	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—MED12—muscle cancer	1.55e-06	0.000717	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	1.54e-06	0.000711	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—MED12—muscle cancer	1.52e-06	0.000702	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—MED12—muscle cancer	1.52e-06	0.000701	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—MED12—muscle cancer	1.44e-06	0.000662	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ENO2—muscle cancer	1.42e-06	0.000654	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ENO2—muscle cancer	1.39e-06	0.00064	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ENO2—muscle cancer	1.39e-06	0.000639	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PTGS2—muscle cancer	1.38e-06	0.000637	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FOXO4—muscle cancer	1.35e-06	0.000621	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CNR1—muscle cancer	1.32e-06	0.00061	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—MED12—muscle cancer	1.32e-06	0.000607	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ENO2—muscle cancer	1.31e-06	0.000603	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—FH—muscle cancer	1.25e-06	0.000576	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ENO2—muscle cancer	1.2e-06	0.000553	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—MED12—muscle cancer	1.17e-06	0.000542	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	1.17e-06	0.000537	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—MED12—muscle cancer	1.15e-06	0.000529	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IGF2—muscle cancer	1.08e-06	0.000498	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—MED12—muscle cancer	1.08e-06	0.000498	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—MED12—muscle cancer	1.07e-06	0.000494	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ENO2—muscle cancer	1.07e-06	0.000494	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ENO2—muscle cancer	1.05e-06	0.000482	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.02e-06	0.000472	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PTGS2—muscle cancer	1.02e-06	0.00047	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FOXO1—muscle cancer	9.95e-07	0.000459	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ENO2—muscle cancer	9.85e-07	0.000454	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ENO2—muscle cancer	9.77e-07	0.00045	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	9.38e-07	0.000433	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—MED12—muscle cancer	9.15e-07	0.000422	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	8.38e-07	0.000386	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ENO2—muscle cancer	8.35e-07	0.000385	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTGS2—muscle cancer	7.69e-07	0.000354	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	7.64e-07	0.000352	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KIT—muscle cancer	7.58e-07	0.000349	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTGS2—muscle cancer	7.4e-07	0.000341	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MED12—muscle cancer	7.06e-07	0.000326	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—muscle cancer	6.73e-07	0.000311	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—muscle cancer	6.68e-07	0.000308	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	6.53e-07	0.000301	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ENO2—muscle cancer	6.44e-07	0.000297	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—muscle cancer	6.12e-07	0.000282	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MDM2—muscle cancer	5.97e-07	0.000275	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—muscle cancer	4.94e-07	0.000228	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—muscle cancer	4.84e-07	0.000223	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—muscle cancer	4.83e-07	0.000222	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—muscle cancer	4.56e-07	0.00021	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—muscle cancer	4.53e-07	0.000209	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—muscle cancer	4.18e-07	0.000193	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—muscle cancer	3.73e-07	0.000172	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—muscle cancer	3.64e-07	0.000168	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—muscle cancer	3.43e-07	0.000158	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—muscle cancer	3.42e-07	0.000158	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—muscle cancer	3.4e-07	0.000157	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—muscle cancer	2.91e-07	0.000134	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—muscle cancer	2.24e-07	0.000103	CbGpPWpGaD
